ArticleAmerican journal of clinical and experimental urology2018

BCL-2 and BCL-XL expression are down-regulated in benign prostate hyperplasia nodules and not affected by finasteride and/or celecoxib.

Feng Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.